Skip to Content

Join the 'Syndros' group to help and get support from people like you.

Syndros News

Insys Therapeutics Announces FDA Approval of Syndros (dronabinol) Oral Solution

Posted 5 Jul 2016 by Drugs.com

PHOENIX, July 05, 2016 (GLOBE NEWSWIRE) – Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the U.S. Food and Drug Administration (FDA) has approved Insys’ dronabinol oral solution, Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol ("THC"). Syndros is approved for use in treating anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. Syndros is currently awaiting scheduling by the U.S. Drug Enforcement Administration. "We are very pleased to announce FDA approval of Syndros. We believe that Syndros will be an important new treatment option for patients suffering from the devastating effects of chemothe ... Read more

Related support groups: Chemotherapy, Anorexia, Nausea/Vomiting - Chemotherapy Induced, AIDS Related Wasting, Dronabinol, Syndros

Ask a Question

Further Information

Related Condition Support Groups

AIDS Related Wasting, Nausea / Vomiting - Chemotherapy Induced, Anorexia

Syndros Patient Information at Drugs.com